John Aballi serves as Executive at EXAGEN INC., where they oversee executive responsibilities. Since joining the company, John Aballi has executed 8 insider transactions totaling $753.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 16, 2025 involved selling 31,787 shares valued at $375.7K.
John Aballi currently holds 714,427 shares of EXAGEN INC. (XGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Aballi has been a net seller of XGN stock. They have purchased $318.8K and sold $434.9K worth of shares.
John Aballi's most recent insider trade was on Oct 16, 2025, when they sold 31,787 shares at $11.82 per share.
Get notified when new Form 4 filings are submitted
| $1.92 |
| Discretionary |
| Feb 29, 2024 | XGN | $18.7K | Award | 9,804 | $1.91 | Discretionary |
| Feb 20, 2024 | XGN | $0 | Award | 175,000 | $N/A | Discretionary |
| Oct 17, 2023 | XGN | $59.2K | Sale | 33,819 | $1.75 | Discretionary |
| Aug 31, 2023 | XGN | $21.0K | Award | 9,803 | $2.14 | Discretionary |
| Dec 8, 2022 | XGN | $241.2K | Purchase | 90,000 | $2.68 | Discretionary |
| Oct 16, 2022 | XGN | $0 | Award | 350,000 | $N/A | Discretionary |